The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global interventional cardiology devices market was valued at US$ 19.58 Billion in 2021.
We expect the global interventional cardiology devices market to exhibit a CAGR of 8.40% during 2022-
The high prevalence of cardiovascular disorders, coupled with the rising utilization of interventional
cardiology for performing cardiovascular procedures, such as angioplasty and stenting, is primarily
driving the global interventional cardiology devices market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cardiovascular
surgeries to reduce the risk of the coronavirus infections upon hospital visits and interaction with
medical equipment, thereby limiting the demand for interventional cardiology devices.
Based on the product, the global interventional cardiology devices market has been segmented into
stents, interventional catheters, PTCA guidewires, balloon inflation device, and PTCA balloons. Currently,
stents hold the majority of the total market share.
Based on the end user, the global interventional cardiology devices market can be divided into hospitals,
ambulatory surgical centers, and others. Among these, hospitals exhibit a clear dominance in the
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global interventional cardiology devices market include Abbott
Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical
Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH,
Koninklijke Philips N.V., Medinol Ltd., Medtronic plc, and Terumo Corporation.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at